African mpox surges show lack of vaccine access
Author:
- Paul AdepojuPAPaul Adepoju
Open Access
- 4 July 2024
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 404 (10447) , 18
Abstract
No abstract availableAll Related Versions
Funding Information
- U.S. Department of Health & Human Services | NIH | Fogarty International Center (R25TW011217, D43TW010937)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5U01AI096299-13)
This publication has 21 references indexed in Scilit:
- The surge of mpox in Africa: a call for actionThe Lancet Global Health, 2024
- Emergence of mpox in the post-smallpox era—a narrative review on mpox epidemiologyClinical Microbiology and Infection, 2023
- APOBEC3F Is a Mutational Driver of the Human Monkeypox Virus Identified in the 2022 OutbreakThe Journal of Infectious Diseases, 2023
- New nomenclature for mpox (monkeypox) and monkeypox virus cladesThe Lancet Infectious Diseases, 2023
- Enhanced surveillance of monkeypox in Bas-Uélé, Democratic Republic of Congo: the limitations of symptom-based case definitionsInternational Journal of Infectious Diseases, 2022
- Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virusNature Medicine, 2022
- Clinical and Epidemiological Findings from Enhanced Monkeypox Surveillance in Tshuapa Province, Democratic Republic of the Congo During 2011–2015The Journal of Infectious Diseases, 2021
- IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic EraMolecular Biology and Evolution, 2020
- Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNAJournal of Virological Methods, 2010
- Dating of the human-ape splitting by a molecular clock of mitochondrial DNAJournal of Molecular Evolution, 1985